Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study

被引:42
|
作者
Syrigos, Konstantinos [1 ]
Grapsa, Dimitra [1 ]
Sangare, Rabiatou [2 ]
Evmorfiadis, Ilias [2 ]
Larsen, Annette K. [2 ]
Van Dreden, Patrick [3 ]
Boura, Paraskevi [1 ]
Charpidou, Andriani [1 ]
Kotteas, Elias [1 ]
Sergentanis, Theodoros N. [4 ]
Elalamy, Ismail [2 ,5 ]
Falanga, Anna [6 ,7 ]
Gerotziafas, Grigoris T. [2 ,5 ]
机构
[1] Univ Athens, Dept Med 3, Oncol Unit, Sch Med,Sotiria Gen Hosp, Athens, Greece
[2] Sorbonne Univ, Fac Med, Ctr Rech St Antoine, Canc Biol & Therapeut,INSERM,U938,IUC, Paris, France
[3] Diagnost Stago, Clin Res Dept, Gennevilliers, France
[4] Hop Univ Est Parisien, Hop Tenon, AP HP, Serv Hematol Biol, Paris, France
[5] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[6] ASST Papa Giovanni XXIII, Dept Immunohematol & Transfus Med, Bergamo, Italy
[7] ASST Papa Giovanni XXIII, Hemostasis & Thrombosis Ctr, Bergamo, Italy
关键词
Lung cancer; Venous thromboembolism; Thrombin generation; Cancer-associated thrombosis; Risk assessment model; PATIENTS RECEIVING CHEMOTHERAPY; VENOUS THROMBOEMBOLISM VTE; PREDICTION; VALIDATION; SCORE; PROPHYLAXIS; ISSUES;
D O I
10.1634/theoncologist.2017-0530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The aim of this prospective study was to identify the most clinically relevant hypercoagulability biomarkers in lung adenocarcinoma patients for elaboration of an improved risk assessment model (RAM) for venous thromboembolism (VTE). Subjects, Materials, and Methods Results One hundred fifty ambulatory patients with lung adenocarcinoma were prospectively enrolled. Thrombin generation, procoagulant phospholipid-dependent clotting time (Procoag-PPL), tissue factor activity (TFa), factor VIIa (FVIIa), factor V (FV), antithrombin, D-Dimers, P-selectin, and heparanase levels were assessed in platelet-poor plasma at inclusion (baseline) and at the end of the third chemotherapy cycle (third chemotherapy). Cox regression analysis was used to identify independent VTE predictors. At baseline, patients had significantly attenuated thrombin generation, shorter Procoag-PPL, higher levels of TFa, D-Dimers, and heparanase, and lower levels of FVIIa and P-selectin, compared with controls. A significant increase in Procoag-PPL, FV, and FVIIa and a decrease of P-selectin levels were observed between baseline and third chemotherapy. Hospitalization within the last 3 months prior to assessment, time since cancer diagnosis less than 6 months, mean rate index (MRI) of thrombin generation, and Procoag-PPL were independently associated with symptomatic VTE. Accordingly, a prediction model including Procoag-PPL and MRI showed significant discriminating capacity (area under the curve: 0.84). Conclusion Implications for Practice Ambulatory patients with lung adenocarcinoma may display pronounced blood hypercoagulability due to decreased Procoag-PPL, increased endothelial cell activation, and increased degradation of fibrin. Incorporation of Procoag-PPL and MRI of thrombin generation may improve the accuracy of a VTE-RAM in the above setting.
引用
收藏
页码:1372 / 1381
页数:10
相关论文
共 50 条
  • [41] Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study
    Cajfinger, F.
    Debourdeau, P.
    Lamblin, A.
    Benatar, V.
    Falvo, N.
    Benhamou, Y.
    Sevestre, M. A.
    Farge-Bancel, D.
    THROMBOSIS RESEARCH, 2016, 144 : 85 - 92
  • [42] Establishment of a risk assessment tool for pregnancy-associated venous thromboembolism and its clinical application: protocol for a prospective observational study in Beijing
    Chen, Yi
    Dai, Yan
    Song, Jing
    Wei, Ling
    Ma, Ying
    Tian, Ning
    Wang, Qian
    Zhang, Qian
    Zhang, Yue
    Wang, Xiao Lan
    Zhang, Jun
    Liu, Rong
    BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (01)
  • [43] Establishment of a risk assessment tool for pregnancy-associated venous thromboembolism and its clinical application: protocol for a prospective observational study in Beijing
    Yi Chen
    Yan Dai
    Jing Song
    Ling Wei
    Ying Ma
    Ning Tian
    Qian Wang
    Qian Zhang
    Yue Zhang
    Xiao Lan Wang
    Jun Zhang
    Rong Liu
    BMC Pregnancy and Childbirth, 19
  • [44] CURRENT STATUS OF OCCURRENCE, RELATED RISK FACTORS AND NURSING INTERVENTIONS OF PICC-ASSOCIATED VENOUS THROMBOSIS IN PATIENTS WITH LUNG CANCER CHEMOTHERAPY
    Cheng Min
    Ding Lili
    Wang Yanli
    Li Huaying
    Lin Xiuqin
    ACTA MEDICA MEDITERRANEA, 2022, 38 (02): : 1009 - 1014
  • [45] Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study
    Pirri, Carlo
    Katris, Paul
    Trotter, James
    Bayliss, Evan
    Bennett, Robert
    Drummond, Peter
    SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1549 - 1563
  • [46] Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data
    Tsubata, Yukari
    Kawakado, Keita
    Hamai, Kosuke
    Furuya, Naoki
    Yokoyama, Toshihide
    Saito, Ryota
    Nakamura, Atsushi
    Masuda, Takeshi
    Hamaguchi, Megumi
    Kuyama, Shoichi
    Honda, Ryoichi
    Senoo, Tadashi
    Nakanishi, Masamoto
    Hotta, Takamasa
    Yamasaki, Masahiro
    Ishikawa, Nobuhisa
    Fujitaka, Kazunori
    Kubota, Tetsuya
    Kobayashi, Kunihiko
    Isobe, Takeshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (01) : 69 - 78
  • [47] Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303)
    Saji, Hisashi
    Ueno, Takahiko
    Nakamura, Hiroshige
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2016, 64 (10) : 634 - +
  • [48] Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303)
    Hisashi Saji
    Takahiko Ueno
    Hiroshige Nakamura
    General Thoracic and Cardiovascular Surgery, 2016, 64 : 634 - 635
  • [49] A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
    Munoz, Andres
    Ay, Cihan
    Grilz, Ella
    Lopez, Sonia
    Font, Carme
    Pachon, Vanesa
    Castellon, Victoria
    Martinez-Marin, Virginia
    Salgado, Mercedes
    Martinez, Eva
    Calzas, Julia
    Ortega, Laura
    Ruperez, Ana
    Salas, Eduardo
    Pabinger, Ingrid
    Soria, Jose Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16) : 2911 - +
  • [50] Factors influencing patient’s perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study
    P. Debourdeau
    P. Arvers
    A. Hij
    H. Bennani
    C. Desauw
    N. Falvo
    F. Ghiringhelli
    A. Hamadé
    L. Vedrine
    D. Farge
    Supportive Care in Cancer, 2020, 28 : 287 - 293